Impact of Etonogestrel Subdermal Implant Versus Depot-Medroxyprogesterone Acetate Injection on Menstrual Changes And Uterine Artery Doppler Indices : A Randomized Clinical Trial

Mathews Journal of Gynecology & Obstetrics Impact of Etonogestrel Subdermal Implant Versus Depot-Medroxyprogesterone Acetate Injection on Menstrual Changes And Uterine Artery Doppler Indices: A Randomized Clinical Trial Mohamed Rezk1*, Osama Elkelani1, Haitham Hamza1, Mohamed Shawky2, Hala Marawan3 1Department of Obstetrics and Gynecology, Egypt. 2Department of Radiology, Egypt. 3Department of Public Health and Community Medicine, Faculty of Medicine, Menoufia University, Egypt. Corresponding Author: Mohamed Rezk, 25 Yasin Abdelghafar street, Shibin ElKom City, Menoufia governorate, Egypt, Tel: +201146256413; Email: m_rezk9207@yahoo.com

[1]  M. Shawky,et al.  RETRACTED ARTICLE: Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users: a prospective observational study , 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[2]  Alai Tan,et al.  Complications and continuation rates associated with 2 types of long-acting contraception. , 2015, American journal of obstetrics and gynecology.

[3]  J. Peipert,et al.  Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. , 2015, American journal of obstetrics and gynecology.

[4]  J. Peipert,et al.  Characteristics Associated With Discontinuation of Long-Acting Reversible Contraception Within the First 6 Months of Use , 2013, Obstetrics and gynecology.

[5]  J. Peipert,et al.  Effectiveness of long-acting reversible contraception. , 2012, The New England journal of medicine.

[6]  P. Inki,et al.  Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: One-year results of an observational study , 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[7]  S. Aggarwal,et al.  Implanon: Subdermal Single Rod Contraceptive Implant , 2011, Journal of obstetrics and gynaecology of India.

[8]  M. Hussein.  Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA , 2011, Archives of Gynecology and Obstetrics.

[9]  L. Lopez,et al.  Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. , 2009, Contraception.

[10]  P. Darney,et al.  Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. , 2009, Contraception.

[11]  P. Darney,et al.  Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. , 2009, Fertility and sterility.

[12]  G. Bachmann,et al.  Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature. , 2009, Contraception.

[13]  A. Çetin,et al.  Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena®) and depot-medroxyprogesterone acetate (Depo-Provera®) on subendometrial microvascularisation and uterine artery blood flow , 2009, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[14]  I. Fraser,et al.  The effects of Implanon® on menstrual bleeding patterns , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[15]  A. Glasier,et al.  Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. , 2006, Contraception.